ConductScience.org, home

Paper428146

Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma a sequential study over 28 days. I. Changes in blood counts, serum immunoglobulins and lymphoid cell populations.

Thatcher N and 2 others. Clin Exp Immunol, 1979. Cited by 7 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma a sequential study over 28 days. I. Changes in blood counts, serum immunoglobulins and lymphoid cell populations. Papers, record 428146. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/428146

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma a sequential study over 28 days. I. Changes in blood counts, serum immunoglobulins and lymphoid cell populations.
PubMed
Journal
Clin Exp Immunol
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.35
iCite
Revised in PubMed
2018-11-13
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Thatcher NN
2Swindell RR
3Crowther DD

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BCG VaccineMajor topic
Bacterial VaccinesMajor topic
MelanomaMajor topic
Propionibacterium acnesMajor topic
Adult
Aged
Female
Humans
Immunoglobulins
Leukocyte Count
Lymphocyte Activation
Male
Middle Aged
Phytohemagglutinins
Receptors, Antigen, B-Cell
Rosette Formation

Source PubMed

Download CSV of topics

References10

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1186417Immunological monitoring and immunotherapy in carcinoma of the lung.Int J Cancer1976https://conductscience.org/library/papers/186417PubMed
2137880Sequential examination of lymphocyte proliferative capacity in patients with malignant melanoma receiving BCG immunotherapy.Int J Cancer1977https://conductscience.org/library/papers/137880PubMed
3300303The effect of adherent and phagocytic cells on human lymphocyte PHA responsiveness.Clin Exp Immunol1977https://conductscience.org/library/papers/300303PubMed
4597473Lymphocyte function and response to chemo-immunotherapy in patients with metastatic melanoma.Br J Cancer1977https://conductscience.org/library/papers/597473PubMed
5588989Postoperative depression of lymphocyte transformation response to microbial antigens.Br J Surg1977https://conductscience.org/library/papers/588989PubMed
64276248Correlation of in vivo and in vitro assays of immunocompetence in cancer patients.Cancer Res1974https://conductscience.org/library/papers/4276248PubMed
71098195Immunodepression after major surgery in normal patients.Surgery1975https://conductscience.org/library/papers/1098195PubMed
84574043Immunosuppressive consequences of radiotherapy and chemotherapy in patients with acute lymphoblastic leukaemia.Br Med J1973https://conductscience.org/library/papers/4574043PubMed
91084821The effect of Corynebacterium parvum on the humoral and cellular immune systems in patients with breast cancer.Clin Exp Immunol1976https://conductscience.org/library/papers/1084821PubMed
10769946Monitoring of immunologic status of patients receiving BCG therapy for malignant disease.Cancer1976https://conductscience.org/library/papers/769946PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
7387858Harmful effects of i.v. Corynebacterium Parvum given at the same time as cyclophosphamide in patients with squamous-cell carcinoma of the bronchus.Br J Cancer1980https://conductscience.org/library/papers/7387858PubMed
7326194Lower relapse rates after neighbourhood injection of Corynebacterium parvum in operable cervix carcinoma.Br J Cancer1981https://conductscience.org/library/papers/7326194PubMed
487647Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly study of melanoma patients II. Changes in serum immunoglobulins and lymphoid cell subpopulations.Clin Exp Immunol1979https://conductscience.org/library/papers/487647PubMed
312169
Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma. A sequential study over 28 days. II. Changes in non-specific (NK, K and T cell) lymphocytoxicity and delayed hypersensitivity skin reactions.
Clin Exp Immunol1979https://conductscience.org/library/papers/312169PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/428146

GET https://conductscience.org/api/papers/v1/428146/authors